Transasia’s wholly owned subsidiary – ERBA Diagnostics Mannheim GmbH, a leading player in the in-vitro diagnostic segment has fortified its presence in the Middle East through its distributor Rashed Al Makhawi Healthcare.
Rashed Al Makhawi Healthcare, a division of Rashed Al Makhawi Enterprises of Dubai, has been the exclusive distributor of the ERBA group for the past eight years. Recently, Rashed Al Makhawi Healthcare brought together the eminent pathologists of UAE who interacted with the team from ERBA Diagnostics Mannheim GmbH at the Hotel Burj Al Arab, Dubai.
The luncheon began with a series of informative presentations by the team from ERBA Mannheim representing their offices in Germany, US and India. Suresh Vazirani, Chairman of Transasia/ERBA Group stated, “We are excited to introduce ERBA Group‘s portfolio to this market. We have had a very successful relationship with Rashed Al Makhawi Healthcare and look forward to watching this grow as we increase our product portfolio. The ERBA Group’s steady expansion is an opportunity to make all our global products available so as to bring the latest to healthcare facilities in this region.”
On this occasion ERBA Diagnostics Mannheim GmbH, presented Rashed Al Makhwai Healthcare with a prestigious award for ‘The Most Promising Distributor.’ On receiving this award, Rashed Al Makhwai Healthcare reiterated its commitment to build ERBA as a stronger brand and market the product extensively in the Middle East.
The invitees also got an opportunity to see the latest products which were on display in the product walk-through section including the DS360 – an HbA1c Analyzer using HPLC technique. The displayed product range reportedly drew much attention from the invitees and finally translated into many orders.
ERBA Mannheim Diagnostics GmbH with the help of its distributor partner Rashed Al Makhwai Healthcare aims to nurture a healthier population in the Middle East.
EH News Bureau
- Advertisement -
